Eurofins Scientific SEERFSF -2.40%77 Return-on-Tangible-Asset is 8.42% as of Dec. 2025, which is 2% below its 10-year median of 8.60. GuruFocus rates ERFSF with a GF Score™ of 77/100 and a GF Value™ of $74.92 (Fairly Valued). The stock has 7 warning signs investors should review. Among 215 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks better than 79.07% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Eurofins Scientific SE's annualizedNet Income for the quarter that ended in Dec. 2025 was $534 Mil. Eurofins Scientific SE's average total tangible assets for the quarter that ended in Dec. 2025 was $6,346 Mil. Therefore, Eurofins Scientific SE's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 8.42%.
The historical rank and industry rank for Eurofins Scientific SE's Return-on-Tangible-Asset or its related term are showing as below:
ERFSF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.09 Med: 8.6 Max: 18.31
Current: 8.81
During the past 13 years, Eurofins Scientific SE's highest Return-on-Tangible-Asset was 18.31%. The lowest was 6.09%. And the median was 8.60%.
ERFSF's Return-on-Tangible-Asset is ranked better than 79.07% of 215
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.4
vs ERFSF: 8.81
Eurofins Scientific SE (OTCPK:ERFSF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Eurofins Scientific SE Return-on-Tangible-Asset Related Terms
Eurofins Scientific SE Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Eurofins Scientific SE's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE Return-on-Tangible-Asset Chart
ERFSF vs TMO, DHR, IDXX: Return-on-Tangible-Asset Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Return-on-Tangible-Asset vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
What does a Return-on-Tangible-Asset of 8.42% mean?
Eurofins Scientific SE (ERFSF) has a Return-on-Tangible-Asset of 8.42% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Eurofins Scientific SE and its competitors. This is near median its historical median of 8.60. Over the past decade, Eurofins Scientific SE's Return-on-Tangible-Asset has ranged from 6.09 to 18.31. According to the industry distribution chart, Eurofins Scientific SE ranks #45 out of 215 companies in the Medical Diagnostics & Research industry, placing it in the top 20.9%.
Is Eurofins Scientific SE's Return-on-Tangible-Asset too high?
Eurofins Scientific SE's current Return-on-Tangible-Asset of 8.42% is near median its 10-year median of 8.60. Over the past 10 years, this metric has ranged from a low of 6.09 to a high of 18.31. Based on the distribution chart, Eurofins Scientific SE ranks #45 out of 215 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Eurofins Scientific SE has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Return-on-Tangible-Asset compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #45 out of 215 companies for Return-on-Tangible-Asset. This places Eurofins Scientific SE in the top 21% of its industry — outperforming the majority of peers. Historically, Eurofins Scientific SE's own Return-on-Tangible-Asset has ranged from 6.09 to 18.31 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Diagnostics & Research company?
A good Return-on-Tangible-Asset depends on the Medical Diagnostics & Research industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Return-on-Tangible-Asset is 8.42%, which is near median its own 10-year median of 8.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $74.92, compared to a current price of $77.54 — trading 3.5% above its estimated fair value. The current Return-on-Tangible-Asset is 8.42%, which is near median its 10-year median of 8.60. Eurofins Scientific SE's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Return-on-Tangible-Asset is 8.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $77.54 is trading 3.5% above its estimated GF Value™ of $74.92.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
Return-on-Tangible-Asset: 8.42% (near median its 10-year median of 8.60)
GF Value™: $74.92 vs. price of $77.54 (3.5% above fair value)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
77GF Score
Get the complete analysis for ERFSF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 
